Get started
TETRALOGIC PHARMACEUTICALS CORPTETRALOGIC PHARMACEUTICALS CORPTETRALOGIC PHARMACEUTICALS CORP

TETRALOGIC PHARMACEUTICALS CORP

No trades
See on Supercharts
OverviewFinancialsMindsTechnicalsSeasonals

Fundamentals and stats

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
TLOG has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company